FindTrial
Sign In

Heart Rate Variability and Stress Response among the Patients with Anxiety and Depression

Correlation of Heart rate variability with severity of anxiety and depression in patients with Generalised anxiety disorder and Major depressive disorder using spandan - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/076476
Enrollment
186
Registered
2024-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder Health Condition 2: F320- Major depressive disorder, singleepisode, mild Health Condition 3: F321- Major depressive disorder, singleepisode, moderate Health Condition 4: F322- Major depressive disorder, singleepisode, severe without psychotic features Health Condition 5: F323- Major depressive disorder, singleepisode, severe with psychotic features Health Condition 6: F324- Major depressive disorder, singleepisode, in partial remission Healt

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Sunfox Technologies Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Psychiatric patient groups that are Diagnosed with specific psychiatric conditions i.e. anxiety and depression under DSM-5 criteria by psychiatrist based on a detailed history. The Control group consists of healthy individuals without any history of psychiatric disorders.

Exclusion criteria

Exclusion criteria: 1. Participants with significant cardiac arrhythmias or underwent some primary coronary interventions. 2. Pregnant or breastfeeding women. 3. Patients with other comorbid psychiatric conditions on the basis of detailed psychiatric interviews.

Design outcomes

Primary

MeasureTime frame
The study will access the correlation of the HRV parameters in time domain and frequency domain for the patients with the Anxiety and depression DisordersTimepoint: 10 weeks—

Secondary

MeasureTime frame
The study may show distinctive HRV patterns between healthy human volunteers and patients with psychiatric conditions. These patterns may include variations in HRV parameters.Timepoint: 12 months;The research may contribute to the identification of early signs or markers of anxiety and depression using HRV analysis. Detecting such signs in a home health care setting through HRV testing could be a crucial step toward early intervention and better mental health outcomes. Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr Sumit Mehta

Shri Guru Ram Rai Institute of Medical and Health Sciences

sumitmehta2010@gmail.com8979609595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026